PMVP insider trading
NasdaqGS HealthcarePMV Pharmaceuticals, Inc.: insider trade history from SEC Form 4 filings.
About PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Company website: www.pmvpharma.com
PMVP insider activity at a glance
FilingIQ tracks 296 insider transactions for PMVP in filings since Sep 29, 2020. The most recent transaction is dated Oct 27, 2025.
Across the full history, 10 open-market purchases
and 181 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on PMVP insider trades is 53.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest PMVP Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for PMVP?
- FilingIQ tracks 296 Form 4 insider transactions for PMVP (PMV Pharmaceuticals, Inc.), covering filings from Sep 29, 2020 onwards. 0 of those are dated within the last 90 days.
- Are PMVP insiders net buyers or net sellers?
- Across the full Form 4 history for PMVP, 10 transactions (3%) were open-market purchases and 181 (61%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PMVP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is PMVP in?
- PMV Pharmaceuticals, Inc. (PMVP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $86.73M.
Methodology & sources
Every PMVP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.